MediView – Weekly Recap

MediView is a private medtech company developing augmented reality imaging solutions for interventional procedures, and this weekly summary highlights fresh progress in clinical engagement and product visibility. The company continues to refine and promote its AR platforms with a focus on real-world usability, workflow integration, and specialty-specific adoption.

During the week, MediView showcased its XR90 augmented reality system at the SOMA 2026 conference, exhibiting at the GE HealthCare booth. The XR90 platform brings 3D X-ray imaging into a clinician’s line of sight for procedural guidance, targeting complex procedures and care settings from frontline environments to operating rooms, including military health.

This presence alongside GE HealthCare at a specialized medical and military forum underscores MediView’s efforts to deepen clinical validation and strengthen strategic relationships. Positioning XR90 within defense-related and high-acuity care markets may enhance the company’s credibility with institutional stakeholders and support future adoption in demanding clinical environments.

MediView also promoted an upcoming educational webinar on May 21 focused on augmented reality in urologic procedures, featuring Dr. Zeyad Schwen. The session will address how 3D image fusion can support more precise targeting, improve visualization of complex anatomy, and enhance workflow efficiency in the procedure room.

By framing the webinar around broader urologic applications and high-quality patient care, the company is highlighting use cases that extend beyond a single procedure type. This educational push is aimed at raising clinician awareness of AR and image-fusion capabilities in urology, including prostate interventions, which could be important for long-term utilization.

These developments build on recent emphasis on intuitive clinician experiences with MediView’s AR tools, particularly in interventional radiology settings. The combined focus on hands-on demonstrations, specialist education, and workflow compatibility suggests a commercialization strategy centered on clinician endorsement and integration into daily practice.

From a market perspective, increased exposure through SOMA 2026 and targeted webinars may support MediView’s positioning in surgical navigation and imaging segments without yet revealing detailed commercial metrics. Overall, the week reflected constructive momentum for MediView as it expands the clinical and strategic footprint of its AR imaging solutions.